Brief: Roquefort Therapeutics To Sell Lyramid For Minimum $10 Mln
Jan 2 (Reuters) - Roquefort Therapeutics PLC ROQ.L :
* PROPOSED SALE OF MIDKINE PORTFOLIO
* TO SELL LYRAMID FOR MINIMUM US$10 MILLION
Source text: ID:nRSB8858Ra
Further company coverage: ROQ.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coiled Therapeutics
See all newsRCS - Coiled Therapeutics - Investor Presentation via Engage Investor
RCS - Coiled Therapeutics - Participation in The Small Cap Showcase
Coiled Therapeutics - Director/PDMR Shareholding
Coiled Therapeutics - Interim Results to 30 June 2026
Coiled Therapeutics - Successful Enrolment Completed Across Two Cohorts